4//SEC Filing
ROBINS CHAD M 4
Accession 0001062993-25-003241
CIK 0001478320other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:28 PM ET
Size
14.5 KB
Accession
0001062993-25-003241
Insider Transaction Report
Form 4
ROBINS CHAD M
DirectorCEO and Chairman
Transactions
- Exercise/Conversion
Common Stock
2025-02-20$6.32/sh+99,107$626,356→ 2,675,808 total - Sale
Common Stock
2025-02-20$8.44/sh−99,107$836,463→ 2,576,701 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-19−186,080→ 99,107 totalExercise: $6.32Exp: 2025-06-09→ Common Stock (186,080 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-02-20−99,107→ 0 totalExercise: $6.32Exp: 2025-06-09→ Common Stock (99,107 underlying) - Exercise/Conversion
Common Stock
2025-02-19$6.32/sh+186,080$1,176,026→ 2,762,781 total - Sale
Common Stock
2025-02-19$8.46/sh−186,080$1,574,237→ 2,576,701 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024. The option would have expired on June 9, 2025.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.67, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.69, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F4]The option is fully vested and exercisable.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780649
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:28 PM ET
- Size
- 14.5 KB